SCHEMBL5283048

SCHEMBL5283048

CC(C)=NN=c1sc(-c2ccc(Cl)cc2)c(-c2ccccc2)n1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
KDM4E B2RXH2 3/20 0.39
LMNA P02545 3/20 0.39
PDE7A Q13946 2/20 0.37
PDE4D Q08499 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
CYP1A2 P05177 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
GBA1 P04062 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
TP53 P04637 4/20 0.33
MDM2 Q00987 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283041 1.00 MAPT (0.39) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL5298274 0.92 ALDH1A1 (0.37) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL5298282 0.92 ALDH1A1 (0.37) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL5282485 0.88 ALOX5 (0.39) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL5280145 0.87 CA1 (0.37) MAPTNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL5290622 0.87 CA1 (0.37) MAPTNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL5283660 0.86 ALOX5 (0.43) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL5278495 0.86 ALOX5 (0.43) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL4613802 0.81 PDE7A (0.40) MAPTNPC1RAB9AKDM4ELMNA
SCHEMBL4613804 0.81 PDE7A (0.40) MAPTNPC1RAB9AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP claimed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US claimed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US claimed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP claimed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO claimed
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAPT 1807/4885NPC1 4843/4885RAB9A 3143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.